Which trial? I see that we should get top line results for Keyzilen during 1st quarter of 2018, and we have a business update and CC next week. But I don't see a drug to be reported on next week.
Ah, phase 3 results for HEALOS trial for AM-111 is supposed to be reported in Q4 2017.